1701 - 1725 of 7916 Results
Title
Year
- Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease2022OPENTitle: Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.889647Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.889647/pdfCitation Count: 27
-
OPENTitle: Unraveling trajectories of diffusive particles on networksJournal Name: Physical Review ResearchPublisher: American Physical Society (APS)Vol: 4Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1103/physrevresearch.4.023182Best OA location URL: http://link.aps.org/pdf/10.1103/PhysRevResearch.4.023182Citation Count: 3
-
RESTRICTEDTitle: Olfaction and apathy in early idiopathic Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 439Issue #:Start Page: 120314End Page: 120314Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2022.120314Citation Count: 2
- Are Virtual Objective Assessments of Fall‐Risk Feasible and Safe for People with Parkinson's Disease?2022OPENTitle: Are Virtual Objective Assessments of Fall‐Risk Feasible and Safe for People with Parkinson's Disease?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 6Start Page: 799End Page: 804Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13494Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13494Citation Count: 6
- Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant2022OPENTitle: Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S VariantJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200737Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484727Citation Count: 4
- ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signaling2022OPENTitle: ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signalingJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202106046Best OA location URL: https://rupress.org/jcb/article-pdf/221/7/e202106046/1434249/jcb_202106046.pdfCitation Count: 50
-
RESTRICTEDTitle: Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s diseaseJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 22Issue #: 6Start Page: 489End Page: 498Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2022.2091436Citation Count: 4
-
RESTRICTEDTitle: Subacute tremor and ataxia: Diligence in pursuit of a diagnosisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 129End Page: 131Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.016Citation Count: 1
-
OPENTitle: Targeted copy number variant identification across the neurodegenerative disease spectrumJournal Name: Molecular Genetics & Genomic MedicinePublisher: WileyVol: 10Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mgg3.1986Best OA location URL: https://ir.lib.uwo.ca/cgi/viewcontent.cgi?article=1101&context=neurosci_inst_pubsCitation Count: 4
- Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting2022OPENTitle: Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle countingJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00330-xBest OA location URL: https://www.nature.com/articles/s41531-022-00330-x.pdfCitation Count: 20
-
OPENTitle: A unifying model for the role of the ATG8 system in autophagyJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 135Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1242/jcs.258997Best OA location URL: https://doi.org/10.1242/jcs.258997Citation Count: 13
-
-
RESTRICTEDTitle: Back to the OfficeJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 3Start Page: 28End Page: 31Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000834412.51769.b3Citation Count: 0
-
OPENTitle: Cellular mechanism of action of 2-nitroimidazoles as hypoxia-selective therapeutic agentsJournal Name: Redox BiologyPublisher: Elsevier BVVol: 52Issue #:Start Page: 102300End Page: 102300Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.redox.2022.102300Best OA location URL: https://doi.org/10.1016/j.redox.2022.102300Citation Count: 8
-
RESTRICTEDTitle: Coaching About Parkinson's DiseaseJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 3Start Page: 7End Page: 8Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000834388.63255.a1Citation Count: 0
-
RESTRICTEDTitle: Cognitive Syndromes Associated With Movement DisordersJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 3Start Page: 726End Page: 749Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/con.0000000000001134Citation Count: 1
- Coping Styles in Patients with Parkinson’s Disease: Consideration in the Co-Designing of Integrated Care Concepts2022OPENTitle: Coping Styles in Patients with Parkinson’s Disease: Consideration in the Co-Designing of Integrated Care ConceptsJournal Name: Journal of Personalized MedicinePublisher: MDPI AGVol: 12Issue #: 6Start Page: 921End Page: 921Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/jpm12060921Best OA location URL: https://www.mdpi.com/2075-4426/12/6/921/pdf?version=1654088438Citation Count: 3
-
RESTRICTEDTitle: Emerging roles of endoplasmic reticulum proteostasis in brain developmentJournal Name: Cells & DevelopmentPublisher: Elsevier BVVol: 170Issue #:Start Page: 203781End Page: 203781Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cdev.2022.203781Best OA location URL: https://doi.org/10.1016/j.cdev.2022.203781Citation Count: 5
- Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson’s in an international setting2022OPENTitle: Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson’s in an international settingJournal Name: BMJ OpenPublisher: BMJVol: 12Issue #: 6Start Page: e049530End Page: e049530Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/bmjopen-2021-049530Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/12/6/e049530.full.pdfCitation Count: 3
-
RESTRICTEDTitle: Glucose-lowering drugs, cognition, and dementia: The clinical evidenceJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 137Issue #:Start Page: 104654End Page: 104654Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neubiorev.2022.104654Best OA location URL: http://manuscript.elsevier.com/S0149763422001439/pdf/S0149763422001439.pdfCitation Count: 8
-
RESTRICTEDTitle: Group Exercise Classes Are Fun and MotivatingJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 3Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000834396.10260.d4Citation Count: 0
-
RESTRICTEDTitle: Immune responses in the Parkinson's disease brainJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 168Issue #:Start Page: 105700End Page: 105700Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105700Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105700Citation Count: 35
- Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s disease2022OPENTitle: Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s diseaseJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 3Issue #: 2Start Page: 101445End Page: 101445Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.xpro.2022.101445Best OA location URL: https://doi.org/10.1016/j.xpro.2022.101445Citation Count: 0
-
RESTRICTEDTitle: Issue OverviewJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.con.0000840008.09408.75Citation Count: 0
-
OPENTitle: Molecular mechanisms defining penetrance of LRRK2-associated Parkinson’s diseaseJournal Name: Medizinische GenetikPublisher: Walter de Gruyter GmbHVol: 34Issue #: 2Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1515/medgen-2022-2127Best OA location URL: https://www.degruyter.com/document/doi/10.1515/medgen-2022-2127/pdfCitation Count: 1